Max Robotics — Global Service Robot Directory + US Certification

About

Paul Cleaveland is a urological researcher whose work focuses on optimizing perioperative care and reducing unnecessary interventions in robot-assisted radical prostatectomy (RARP). His most cited study, "New recommendations to reduce unnecessary blood tests after robot‐assisted radical prostatectomy" (2021), addresses a critical gap in postoperative management by identifying evidence-based strategies to minimize routine blood work without compromising patient safety. This contribution has practical implications for streamlining clinical workflows and reducing healthcare costs, earning 3 citations to date. Cleaveland’s research aligns with broader efforts to enhance recovery protocols and refine surgical outcomes for localized prostate cancer, a field where RARP has become a gold standard due to its lower complication rates and reduced blood loss. While his citation count is modest, his work reflects a growing emphasis on value-based care in urology. Cleaveland’s dedication to improving patient outcomes through data-driven recommendations positions him as a thoughtful contributor to the ongoing evolution of prostate cancer treatment.